glp-1 agonist brand names GLP-1R agonists approved by the United States FDA and international glp-1 receptor agonist brand names
Description
Insurance requirements vary by plan, so you should call your insurance provider to see if they cover these options and to find out any additional requirements
Paracrine regulation of insulin secretion
Adapted from Kuritzky et al
Combination Therapy: DPP-4 inhibitors may be used as monotherapy in individuals with mild to moderate diabetes who are non-compliant or intolerant of metformin and other first-line agents
